ConductScience.org, home

Paper41579307

A case of bucillamine-induced membranous nephropathy presenting with acute kidney injury and requiring hemodialysis.

Otani H and 16 others. CEN Case Rep, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. A case of bucillamine-induced membranous nephropathy presenting with acute kidney injury and requiring hemodialysis. Papers, record 41579307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41579307

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A case of bucillamine-induced membranous nephropathy presenting with acute kidney injury and requiring hemodialysis.
PubMed
Journal
CEN Case Rep
PubMed
Year
2026
PubMed
Publication types
Journal Article, Case Reports
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-01
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Otani HHitomi
2Suwabe TTatsuya
3Oba YYuki
4Mizuno HHiroki
5Sekine AAkinari
6Yamanouchi MMasayuki
7Hasegawa EEiko
8Kono KKei
9Fujii TTakeshi
10Takazawa YYutaka
11Ohashi KKenichi
12Wada TTakehiko
13Nakano MMarie
14Miyabe YYoei
15Hoshino JJunichi
16Sawa NNaoki
17Ubara YYoshifumi

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acute Kidney InjuryMajor topic
Glomerulonephritis, MembranousMajor topic
Renal DialysisMajor topic
CysteineMajor topic
Humans
Male
Aged
Proteinuria
Biopsy
Arthritis, Rheumatoid
Kidney
Microscopy, Electron

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119571279M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.N Engl J Med2009https://conductscience.org/library/papers/19571279PubMed
28995742IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis.Kidney Int1997https://conductscience.org/library/papers/8995742PubMed
334370109Correction to: Kidney biopsy guidebook 2020 in Japan.Clin Exp Nephrol2021https://conductscience.org/library/papers/34370109PubMed
42239933Adult minimal change glomerulopathy with acute renal failure.Am J Kidney Dis1990https://conductscience.org/library/papers/2239933PubMed
539249508Clinicopathological characteristics of neural epidermal growth factor-like 1 protein-associated membranous glomerulonephritis.Virchows Arch2025https://conductscience.org/library/papers/39249508PubMed
631901340Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy.Kidney Int2020https://conductscience.org/library/papers/31901340PubMed
734846624Use of biologic agents and methotrexate improves renal manifestation and outcome in patients with rheumatoid arthritis: a retrospective analysis.Clin Exp Nephrol2022https://conductscience.org/library/papers/34846624PubMed
831037495Membranous nephropathy caused by rheumatoid arthritis.CEN Case Rep2019https://conductscience.org/library/papers/31037495PubMed
937069980Neural Epidermal Growth Factor-Like 1-Positive Membranous Nephropathy With Rheumatoid Arthritis.Kidney Int Rep2023https://conductscience.org/library/papers/37069980PubMed
1038596642NELL1 membranous nephropathy: clinical associations provide mechanistic clues.Front Nephrol2024https://conductscience.org/library/papers/38596642PubMed
1139990895NELL-1-Associated Membranous Nephropathy Induced by Long-Term Penicillamine Treatment in a Patient With Wilson's Disease.Kidney Int Rep2025https://conductscience.org/library/papers/39990895PubMed
1216685139Outcome and treatment of bucillamine-induced nephropathy.Nephron Clin Pract2006https://conductscience.org/library/papers/16685139PubMed
1340050703Bucillamine-induced membranous nephropathy versus primary membranous nephropathy: comparing pathological features and kidney prognosis.Sci Rep2025https://conductscience.org/library/papers/40050703PubMed
1433606126Kidney biopsy guidebook 2020 in Japan.Clin Exp Nephrol2021https://conductscience.org/library/papers/33606126PubMed
1537547509Adding Cases to the Study of Bucillamine-Associated Neural Epidermal Growth Factor-Like1-Positive Membranous Nephropathy.Kidney Int Rep2023https://conductscience.org/library/papers/37547509PubMed
1611920335Bucillamine induces membranous glomerulonephritis.Am J Kidney Dis2002https://conductscience.org/library/papers/11920335PubMed
1733344486Secondary Membranous Nephropathy. A Narrative Review.Front Med (Lausanne)2020https://conductscience.org/library/papers/33344486PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41579307

GET https://conductscience.org/api/papers/v1/41579307/authors